aTYR PHARMA (ATYR) Total Debt (2014 - 2020)

aTYR PHARMA (ATYR) has reported Total Debt for 7 consecutive years, with $3.1 million the latest figure, recorded in Q3 2020.

• For the quarter ending Q3 2020, Total Debt fell 71.08% year-over-year to $3.1 million; the trailing twelve-month figure through Sep 2020 stood at $3.1 million (down 71.08% YoY), and the FY2019 full-year result was $8.7 million, down 45.5% from the prior year.
• Total Debt eased to $3.1 million in Q3 2020 per ATYR's latest filing, from $5.0 million in the prior quarter.
• Across five years, Total Debt topped out at $20.0 million in Q1 2018 and bottomed at $2.6 million in Q3 2016.
• Historically, Total Debt has averaged $11.2 million across 5 years, with a median of $10.6 million in 2019.
• The sharpest annual moves came in 2017 and 2020: Total Debt jumped 458.56% in 2017, then plunged 71.08% in 2020.
• Over 5 years, Total Debt stood at $9.5 million in 2016, then surged by 106.89% to $19.7 million in 2017, then retreated by 18.76% to $16.0 million in 2018, then plunged by 45.5% to $8.7 million in 2019, then sank by 64.97% to $3.1 million in 2020.
• According to Business Quant data, Total Debt over the past three periods registered $3.1 million, $5.0 million, and $6.9 million for Q3 2020, Q2 2020, and Q1 2020 respectively.